In a significant move that’s turning heads in the fertility benefits industry, e-commerce giant Amazon has reportedly chosen Maven Clinic to replace Progyny as its primary fertility benefits provider. This development, highlighted in a recent J.P. Morgan analyst report, marks a notable moment in the competitive landscape of digital health and family care services. Anu Duggal, an investor in Maven through Female…
Medtech company ASPIVIX has announced a new partnership with Tia, the U.S. based women’s health clinic network, to enhance the IUD insertion experience. This collaboration will introduce ASPIVIX’s Carevix, a device designed to reduce pain during IUD insertions, at nine Tia clinics located in Los Angeles, New York, San Francisco, and Scottsdale. The partnership reflects a shared mission between ASPIVIX and Tia…
Cercle, an AI company transforming women’s healthcare data into actionable insights, has raised $6 million in a seed funding round led by Outsiders Fund. Other investors include FemHealth Ventures, CGHealth Ventures, Rogue Women’s Fund, and existing backers like Sheryl Sandberg and Tom Bernthal’s SBVP fund. This new funding will support Cercle’s expansion beyond the fertility market, improve its AI-driven platform, and enhance…
Wisp, a leading telehealth provider specializing in women’s sexual and reproductive health, has recently achieved a significant milestone: serving over one million patients. Founded with the aim of becoming a comprehensive provider for women’s health needs, Wisp has expanded its services to cover various aspects of women’s health over the past few years from birth control to fertility services and menopause care.…
HeyFlow, a female reproductive health inclusion business aiming to end workplace disadvantages for women, has secured a £235,000 investment from Aer Venture Studios. This funding will support the development and architecture of HeyFlow’s tech platform and employee insight product, enabling the company to expand its reach to more enterprise clients both nationally and globally. HeyFlow is the inaugural investment client for Aer…
U-Ploid, a venture-backed biotech company, has introduced its new platform designed to enhance the quality of older egg cells, a critical factor in increasing the success rates of in vitro fertilization (IVF) for women experiencing age-related infertility. The company’s technology aims to repair decades of accumulated damage in eggs, thereby improving their viability during IVF treatments. Age-related fertility decline affects millions worldwide,…
Organon China has announced a licensing and supply agreement with Shanghai Bao Pharmaceutical (BaoPharma) and its wholly-owned subsidiary, Suzhou Centergene Pharmaceuticals. Through this partnership, Organon acquires the exclusive commercialization rights to Centergene’s investigational asset, SJ02, in Mainland China. SJ02, developed by Centergene, is a long-acting recombinant human follicle-stimulating hormone carboxyl-terminal peptide fusion protein (FSH-CTP). It is designed for controlled ovarian stimulation (COS)…
Femasys, a biomedical company specializing in women’s health, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for FemChec, adiagnostic tool for checking the fallopian tubes. This new solution is designed for controlled delivery of contrast media, allowing for clearer confirmation of tubal status during ultrasound evaluations. Kathy Lee-Sepsick, founder and CEO of Femasys,…
